Gary Leibler
Managing Director @ Shavit Capital
Gary Leibler is a Series F investor at Shavit Capital focused on Health Care and Therapeutics. Gary Leibler is well-positioned to lead the Fund having held prominent positions in the investment and finance industry, in addition to having experience as an attorney and accountant.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Gary Leibler invests in
Stages Gary Leibler invests in
Countries Gary Leibler invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Gamida Cell is dedicated to making a significant difference in the clinical practice of modern medicine by first creating, then tapping the regenerative power of therapeutic stem cells. Gamida Cell is a leader in the development of stem cell therapy technologies and products. The therapies are based on expanded populations of cord blood stem cells,for the treatment of illnesses with significant unmet clinical needs such as blood cancers, autoimmune and metabolic diseases as well as neutropenia. | $40M / Series F / Jun 19, 2017 |
Co-Investors
About Shavit Capital
Shavit Capital Fund is a private equity fund investing primarily in Israeli related companies with a clear path to an IPO (mezzanine rounds) and public companies traded in the US, Israel or other international markets (PIPE/secondary offerings).The Fund seeks investment opportunities in successful, small to medium-sized companies withstrong management teams and demonstrated growth potential
Shavit Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Gary Leibler
Managing Director
|
|||
|
Leon Recanati
Chairman
|
|||
|
Leon Recanati
Co-Founding Partner & Chairman
|
|||
|
Neil Cohen
Venture Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Gary Leibler invest in?
Gary Leibler invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series F stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Gary Leibler?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Gary Leibler last invest?
The most recent investment recorded for Gary Leibler closed in Jun 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!